Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

By Powell B.L.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 65-68

Springer Publishing Company

Access to resources Recommend Favorite

Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer

By Derin Duygu   Eralp Yesim   Ozluk Yasemin   Yavuz Ekrem   Guney Nese   Saip Pinar   Igci Abdullah   Ozmen Vahit   Kucucuk Seden   Aslay Isik   Aydiner Adnan   Topuz Erkan  

Cancer Investigation, Vol. 26, Iss. 7, 2008-08 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

Differential Gene Expression of BRCA1, ERBB2 and TP53 Biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 4, 2016-02 ,pp. : 519-525

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1531-1536

Spandidos Publications

Access to resources Recommend Favorite